{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/PVLA/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-15T13:34:40.615Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":9660,"canonical_name":"PALVELLA THERAPEUTICS, INC.","cik":"0001583648","uei":null,"lei":null,"duns":null,"ticker":"PVLA"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":40},"count":40,"timeline":[{"ts":"2026-09-18","kind":"sec.filing","form_type":"4","title":"4 — PALVELLA THERAPEUTICS, INC. — 2026-09-18","url_slug":"/sec/cik-0001583648/4/0001104659-26-108930","accession_number":"0001104659-26-108930","importance":30},{"ts":"2026-09-16","kind":"sec.filing","form_type":"144","title":"144 — PALVELLA THERAPEUTICS, INC. — 2026-09-16","url_slug":"/sec/cik-0001583648/144/0001967940-26-000051","accession_number":"0001967940-26-000051","importance":30},{"ts":"2026-09-11","kind":"sec.form144","reporter":"JENKINS GEORGE M","title":"Director","shares":27500,"usd_value":4135725,"security_title":"Common Stock","approx_sale_date":"2026-09-11","accession_number":"0001967940-26-000050","importance":40.827145},{"ts":"2026-08-20","kind":"sec.filing","form_type":"4","title":"4 — PALVELLA THERAPEUTICS, INC. — 2026-08-20","url_slug":"/sec/cik-0001583648/4/0001104659-26-099222","accession_number":"0001104659-26-099222","importance":30},{"ts":"2026-08-19","kind":"sec.filing","form_type":"144","title":"144 — PALVELLA THERAPEUTICS, INC. — 2026-08-19","url_slug":"/sec/cik-0001583648/144/0001967940-26-000044","accession_number":"0001967940-26-000044","importance":30},{"ts":"2026-08-14","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — PALVELLA THERAPEUTICS, INC. — 2026-08-14","url_slug":"/sec/cik-0001583648/schedule-13g-a/0000921895-26-002180","accession_number":"0000921895-26-002180","importance":30},{"ts":"2026-08-14","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — PALVELLA THERAPEUTICS, INC. — 2026-08-14","url_slug":"/sec/cik-0001583648/schedule-13g-a/0001999371-26-018011","accession_number":"0001999371-26-018011","importance":30},{"ts":"2026-08-04","kind":"sec.filing","form_type":"10-Q","title":"10-Q — PALVELLA THERAPEUTICS, INC. — 2026-08-04","url_slug":"/sec/cik-0001583648/10-q/0001193125-26-331574","accession_number":"0001193125-26-331574","importance":45},{"ts":"2026-08-04","kind":"sec.filing","form_type":"8-K","title":"8-K — PALVELLA THERAPEUTICS, INC. — 2026-08-04","url_slug":"/sec/cik-0001583648/8-k/0001193125-26-331556","accession_number":"0001193125-26-331556","importance":35},{"ts":"2026-08-04","kind":"sec.filing","form_type":"S-8","title":"S-8 — PALVELLA THERAPEUTICS, INC. — 2026-08-04","url_slug":"/sec/cik-0001583648/s-8/0001104659-26-090394","accession_number":"0001104659-26-090394","importance":30},{"ts":"2026-08-03","kind":"sec.filing","form_type":"SCHEDULE 13G","title":"SCHEDULE 13G — PALVELLA THERAPEUTICS, INC. — 2026-08-03","url_slug":"/sec/cik-0001583648/schedule-13g/0000053417-26-000050","accession_number":"0000053417-26-000050","importance":55},{"ts":"2026-07-29","kind":"sec.filing","form_type":"SCHEDULE 13G","title":"SCHEDULE 13G — PALVELLA THERAPEUTICS, INC. — 2026-07-29","url_slug":"/sec/cik-0001583648/schedule-13g/0002012383-26-002924","accession_number":"0002012383-26-002924","importance":55},{"ts":"2026-07-15","kind":"sec.form144","reporter":"Goin Kathleen","title":"Officer","shares":4302,"usd_value":643923,"security_title":"Common Stock","approx_sale_date":"2026-07-15","accession_number":"0001967940-26-000039","importance":40.128784672},{"ts":"2026-07-15","kind":"sec.insider.s","reporter":"Goin Kathleen","title":"Chief Operating Officer","shares":1911,"price_per_share":150.2529,"usd_value":287133,"security_title":"Common Stock","importance":35.2871332919},{"ts":"2026-07-15","kind":"sec.insider.s","reporter":"Goin Kathleen","title":"Chief Operating Officer","shares":1029,"price_per_share":149.2667,"usd_value":153595,"security_title":"Common Stock","importance":35.1535954343},{"ts":"2026-07-15","kind":"sec.insider.s","reporter":"Goin Kathleen","title":"Chief Operating Officer","shares":840,"price_per_share":148.4018,"usd_value":124658,"security_title":"Common Stock","importance":35.124657512},{"ts":"2026-07-15","kind":"sec.insider.s","reporter":"Goin Kathleen","title":"Chief Operating Officer","shares":522,"price_per_share":147.1365,"usd_value":76805,"security_title":"Common Stock","importance":35.076805253},{"ts":"2026-07-15","kind":"sec.filing","form_type":"144","title":"144 — PALVELLA THERAPEUTICS, INC. — 2026-07-15","url_slug":"/sec/cik-0001583648/144/0001967940-26-000039","accession_number":"0001967940-26-000039","importance":30},{"ts":"2026-07-15","kind":"sec.insider.m","reporter":"Goin Kathleen","title":"Chief Operating Officer","shares":2148,"price_per_share":9.08,"usd_value":19504,"security_title":"Common Stock","importance":15.01950384},{"ts":"2026-07-15","kind":"sec.insider.m","reporter":"Goin Kathleen","title":"Chief Operating Officer","shares":2154,"price_per_share":7.14,"usd_value":15380,"security_title":"Common Stock","importance":15.01537956},{"ts":"2026-07-14","kind":"sec.filing","form_type":"8-K","title":"8-K — PALVELLA THERAPEUTICS, INC. — 2026-07-14","url_slug":"/sec/cik-0001583648/8-k/0001193125-26-303307","accession_number":"0001193125-26-303307","importance":35},{"ts":"2026-06-30","kind":"sec.filing","form_type":"8-K","title":"8-K — PALVELLA THERAPEUTICS, INC. — 2026-06-30","url_slug":"/sec/cik-0001583648/8-k/0001104659-26-079087","accession_number":"0001104659-26-079087","importance":35},{"ts":"2026-06-22","kind":"sec.filing","form_type":"4","title":"4 — PALVELLA THERAPEUTICS, INC. — 2026-06-22","url_slug":"/sec/cik-0001583648/4/0001104659-26-076460","accession_number":"0001104659-26-076460","importance":30},{"ts":"2026-06-17","kind":"sec.form144","reporter":"Goin Kathleen","title":"Officer","shares":4302,"usd_value":476373,"security_title":"Common Stock","approx_sale_date":"2026-06-17","accession_number":"0001967940-26-000032","importance":40.095274588},{"ts":"2026-06-17","kind":"sec.insider.s","reporter":"Goin Kathleen","title":"Chief Operating Officer","shares":2390,"price_per_share":110.2594,"usd_value":263520,"security_title":"Common Stock","importance":35.263519966},{"ts":"2026-06-17","kind":"sec.insider.s","reporter":"Goin Kathleen","title":"Chief Operating Officer","shares":1887,"price_per_share":111.3128,"usd_value":210047,"security_title":"Common Stock","importance":35.2100472536},{"ts":"2026-06-17","kind":"sec.insider.s","reporter":"Goin Kathleen","title":"Chief Operating Officer","shares":25,"price_per_share":112.23,"usd_value":2806,"security_title":"Common Stock","importance":35.00280575},{"ts":"2026-06-17","kind":"sec.filing","form_type":"144","title":"144 — PALVELLA THERAPEUTICS, INC. — 2026-06-17","url_slug":"/sec/cik-0001583648/144/0001967940-26-000032","accession_number":"0001967940-26-000032","importance":30},{"ts":"2026-06-17","kind":"sec.insider.m","reporter":"Goin Kathleen","title":"Chief Operating Officer","shares":2148,"price_per_share":9.08,"usd_value":19504,"security_title":"Common Stock","importance":15.01950384},{"ts":"2026-06-17","kind":"sec.insider.m","reporter":"Goin Kathleen","title":"Chief Operating Officer","shares":2154,"price_per_share":7.14,"usd_value":15380,"security_title":"Common Stock","importance":15.01537956},{"ts":"2026-06-16","kind":"sec.filing","form_type":"8-K","title":"8-K — PALVELLA THERAPEUTICS, INC. — 2026-06-16","url_slug":"/sec/cik-0001583648/8-k/0001104659-26-074338","accession_number":"0001104659-26-074338","importance":35},{"ts":"2026-06-16","kind":"sec.filing","form_type":"4","title":"4 — PALVELLA THERAPEUTICS, INC. — 2026-06-16","url_slug":"/sec/cik-0001583648/4/0001104659-26-074574","accession_number":"0001104659-26-074574","importance":30},{"ts":"2026-06-12","kind":"sec.filing","form_type":"4","title":"4 — PALVELLA THERAPEUTICS, INC. — 2026-06-12","url_slug":"/sec/cik-0001583648/4/0001104659-26-073420","accession_number":"0001104659-26-073420","importance":30},{"ts":"2026-06-12","kind":"sec.filing","form_type":"4","title":"4 — PALVELLA THERAPEUTICS, INC. — 2026-06-12","url_slug":"/sec/cik-0001583648/4/0001104659-26-073432","accession_number":"0001104659-26-073432","importance":30},{"ts":"2026-06-12","kind":"sec.insider.m","reporter":"Korenberg Matthew E","title":"CFO, Treasurer","shares":1000,"price_per_share":13.6,"usd_value":13600,"security_title":"Common Stock","importance":15.0136},{"ts":"2026-05-20","kind":"sec.form144","reporter":"Goin Kathleen","title":"Officer","shares":4302,"usd_value":475631,"security_title":"Common Stock","approx_sale_date":"2026-05-20","accession_number":"0001967940-26-000016","importance":40.095126168},{"ts":"2026-05-20","kind":"sec.filing","form_type":"8-K","title":"8-K — PALVELLA THERAPEUTICS, INC. — 2026-05-20","url_slug":"/sec/cik-0001583648/8-k/0001193125-26-232717","accession_number":"0001193125-26-232717","importance":35},{"ts":"2026-05-20","kind":"sec.filing","form_type":"144","title":"144 — PALVELLA THERAPEUTICS, INC. — 2026-05-20","url_slug":"/sec/cik-0001583648/144/0001967940-26-000016","accession_number":"0001967940-26-000016","importance":30},{"ts":"2026-05-15","kind":"sec.filing","form_type":"8-K","title":"8-K — PALVELLA THERAPEUTICS, INC. — 2026-05-15","url_slug":"/sec/cik-0001583648/8-k/0001193125-26-225317","accession_number":"0001193125-26-225317","importance":35},{"ts":"2026-05-13","kind":"sec.filing","form_type":"8-K","title":"8-K — PALVELLA THERAPEUTICS, INC. — 2026-05-13","url_slug":"/sec/cik-0001583648/8-k/0001193125-26-220607","accession_number":"0001193125-26-220607","importance":35}]}